Brief: Rubius Therapeutics Reports Q2 Loss Per Share $0.50
13/08/2019 13:18
Aug 13 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS REPORTS SECOND QUARTER 2019 FINANCIAL
RESULTS AND OPERATIONAL PROGRESS
* Q2 EARNINGS PER SHARE ESTIMATE $-0.45 -- REFINITIV IBES
DATA
* Q2 LOSS PER SHARE $0.50
* RUBIUS THERAPEUTICS - AS OF JUNE 30, 2019, CASH, CASH
EQUIVALENTS AND INVESTMENTS WERE $362.3 MILLION AS COMPARED TO
$404.1 MILLION AS OF DECEMBER 31, 2018
Source text for Eikon: ID:nGNXb4pfbx
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft